Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report) passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 42.31 ($0.57) and traded as high as GBX 46.87 ($0.63). Beximco Pharmaceuticals shares last traded at GBX 46.87 ($0.63), with a volume of 1,000 shares trading hands.
Beximco Pharmaceuticals Stock Performance
The firm has a market cap of £203.52 million, a P/E ratio of 3.20 and a beta of 0.61. The stock's 50 day moving average is GBX 42.93 and its two-hundred day moving average is GBX 39.40. The company has a debt-to-equity ratio of 12.47, a current ratio of 2.13 and a quick ratio of 0.37.
Beximco Pharmaceuticals Company Profile
(
Get Free Report)
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands.
Recommended Stories
Before you consider Beximco Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beximco Pharmaceuticals wasn't on the list.
While Beximco Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
